← back to search

Eric Mou

Stanford Medicine · US
Area of research
Pathology and Forensic Medicine · Dermatology
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Cutaneous lymphoproliferative disorders research, CNS Lymphoma Diagnosis and Treatment, and Chronic Lymphocytic Leukemia Research.
h-index
9
citations
427
works
96
NIH funding
primary concept
Medicine
email

Recent publications

Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma
Blood Advances 2025cited by 4position: middledoi
Gene expression profiling reveals 2 overarching types of ALCL with distinct targetable biology: an LLMPP study
Blood 2025cited by 3position: middledoi
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma
Blood Advances 2022cited by 35position: middledoi
Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma
Blood Advances 2021cited by 29position: middledoi
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma
Blood 2020cited by 138position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ranjana H. Advani · Stanford Medicine3 papers (2020–2022)Andrew M. Evens · Rutgers, The State University of New Jersey3 papers (2020–2022)Kaitlyn O’Shea · Northwestern Medicine2 papers (2020–2022)Hatice Savas · Northwestern Medicine2 papers (2020–2022)Brett Alan Palmer · Northwestern University2 papers (2020–2022)Joan S. Chmiel · Northwestern University2 papers (2020–2022)Robert Bayer · Northwestern University2 papers (2020–2022)Reem Karmali · Northwestern University2 papers (2020–2022)Jane N. Winter · Northwestern University2 papers (2020–2022)Gary Dillehay · Northwestern University2 papers (2020–2022)Leo I. Gordon · Northwestern University2 papers (2020–2022)Barbara Pro · Columbia University Irving Medical Center2 papers (2020–2022)Robert Eisner · NorthShore University HealthSystem2 papers (2020–2022)Pamela B. Allen · Emory University2 papers (2020–2022)Xinyan Lu · Texas Children's Hospital1 papers (2022–2022) · 1 papers (2021–2021) · 1 papers (2022–2022)Qing Chen · Nanjing University of Chinese Medicine1 papers (2022–2022)Victor M. Orellana‐Noia · Winship Cancer Institute1 papers (2021–2021)Mary‐Kate Malecek · Washington University in St. Louis1 papers (2021–2021)